Jacobs Levy Equity Management’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-81,891
| Closed | -$411K | – | 1076 |
|
|
2021
Q4 | $411K | Sell |
81,891
-20,316
| -20% | -$102K | ﹤0.01% | 859 |
|
|
2021
Q3 | $680K | Sell |
102,207
-36,397
| -26% | -$242K | ﹤0.01% | 822 |
|
|
2021
Q2 | $847K | Sell |
138,604
-2,363
| -2% | -$14.4K | 0.01% | 773 |
|
|
2021
Q1 | $937K | Buy |
140,967
+114,803
| +439% | +$763K | 0.01% | 750 |
|
|
2020
Q4 | $138K | Buy |
+26,164
| New | +$138K | ﹤0.01% | 980 |
|
|
2020
Q1 | – | Sell |
-17,791
| Closed | -$101K | – | 1083 |
|
|
2019
Q4 | $101K | Buy |
17,791
+3,157
| +22% | +$17.9K | ﹤0.01% | 975 |
|
|
2019
Q3 | $86K | Sell |
14,634
-22,287
| -60% | -$131K | ﹤0.01% | 896 |
|
|
2019
Q2 | $118K | Buy |
36,921
+13,225
| +56% | +$42.3K | ﹤0.01% | 910 |
|
|
2019
Q1 | $71K | Buy |
+23,696
| New | +$71K | ﹤0.01% | 941 |
|